{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:12:59Z","timestamp":1791465179165,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/onc.2014.319","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T10:31:30Z","timestamp":1411986690000},"page":"3780-3790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation"],"prefix":"10.1038","volume":"34","author":[{"given":"M P","family":"Licciardello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M K","family":"M\u00fcllner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"D\u00fcrnberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Kerzendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Boidol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Trefzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sdelci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Penz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kralovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-1768","authenticated-orcid":false,"given":"G","family":"Superti-Furga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Colinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Nijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kubicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,29]]},"reference":[{"key":"BFonc2014319_CR1","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1038\/485S50a","volume":"485","author":"A Maxmen","year":"2012","unstructured":"Maxmen A . The hard facts. Nature 2012; 485: S50\u2013S51.","journal-title":"Nature"},{"key":"BFonc2014319_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature11017","volume":"486","author":"PJ Stephens","year":"2012","unstructured":"Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012; 486: 400\u2013404.","journal-title":"Nature"},{"key":"BFonc2014319_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ et al. The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature 2012; 486: 346\u2013352.","journal-title":"Nature"},{"key":"BFonc2014319_CR4","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61\u201370.","DOI":"10.1038\/nature11412"},{"key":"BFonc2014319_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.1073096","volume":"297","author":"IB Weinstein","year":"2002","unstructured":"Weinstein IB . Addiction to oncogenes-the Achilles heal of cancer. Science 2002; 297: 63\u201364.","journal-title":"Science"},{"key":"BFonc2014319_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New Engl J Med 2001; 344: 1031\u20131037.","journal-title":"New Engl J Med"},{"key":"BFonc2014319_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1200\/JCO.2002.20.3.719","volume":"20","author":"CL Vogel","year":"2002","unstructured":"Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 2002; 20: 719\u2013726.","journal-title":"J Clin Oncol"},{"key":"BFonc2014319_CR8","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","volume":"363","author":"KT Flaherty","year":"2010","unstructured":"Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA et al. Inhibition of mutated, activated BRAF in metastatic melanoma. New Engl J Med 2010; 363: 809\u2013819.","journal-title":"New Engl J Med"},{"key":"BFonc2014319_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","volume":"136","author":"J Luo","year":"2009","unstructured":"Luo J, Solimini NL, Elledge SJ . Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 2009; 136: 823\u2013837.","journal-title":"Cell"},{"key":"BFonc2014319_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrc1691","volume":"5","author":"WG Kaelin","year":"2005","unstructured":"Kaelin WG . The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 2005; 5: 689\u2013698.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014319_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.febslet.2010.11.024","volume":"585","author":"SMB Nijman","year":"2011","unstructured":"Nijman SMB . Synthetic lethality: general principles, utility and detection using genetic screens in human cells. FEBS Lett 2011; 585: 1\u20136.","journal-title":"FEBS Lett"},{"key":"BFonc2014319_CR12","doi-asserted-by":"publisher","first-page":"10314","DOI":"10.1073\/pnas.171076798","volume":"98","author":"MS Neshat","year":"2001","unstructured":"Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR. Proc Natl Acad Sci 2001; 98: 10314\u201310319.","journal-title":"Proc Natl Acad Sci"},{"key":"BFonc2014319_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"PC Fong","year":"2009","unstructured":"Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. New Engl J Med 2009; 361: 123\u2013134.","journal-title":"New Engl J Med"},{"key":"BFonc2014319_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2014.01.001","volume":"35","author":"B Mair","year":"2014","unstructured":"Mair B, Kubicek S, Nijman SM . Exploiting epigenetic vulnerabilities for cancer therapeutics. Trends Pharmacol Sci 2014; 35: 136\u2013145.","journal-title":"Trends Pharmacol Sci"},{"key":"BFonc2014319_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2013.01.017","volume":"152","author":"G Johnson David","year":"2013","unstructured":"Johnson David G, Dent Sharon YR . Chromatin: receiver and quarterback for cellular signals. Cell 2013; 152: 685\u2013689.","journal-title":"Cell"},{"key":"BFonc2014319_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/1535-7163.MCT-10-0677","volume":"10","author":"H Al-Hussaini","year":"2010","unstructured":"Al-Hussaini H, Subramanyam D, Reedijk M, Sridhar SS . Notch signaling pathway as a therapeutic target in breast cancer. Mol Cancer Ther 2010; 10: 9\u201315.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2014319_CR17","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.1073\/pnas.1000896107","volume":"107","author":"M Mazzone","year":"2010","unstructured":"Mazzone M, Selfors LM, Albeck J, Overholtzer M, Sale S, Carroll DL et al. Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc Natl Acad Sci 2010; 107: 5012\u20135017.","journal-title":"Proc Natl Acad Sci"},{"key":"BFonc2014319_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan R, Ilagan MXG . The canonical notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137: 216\u2013233.","journal-title":"Cell"},{"key":"BFonc2014319_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2010.01.004","volume":"32","author":"F Radtke","year":"2010","unstructured":"Radtke F, Fasnacht N, MacDonald HR . Notch signaling in the immune system. Immunity 2010; 32: 14\u201327.","journal-title":"Immunity"},{"key":"BFonc2014319_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nri2304","volume":"8","author":"I Aifantis","year":"2008","unstructured":"Aifantis I, Raetz E, Buonamici S . Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008; 8: 380\u2013390.","journal-title":"Nat Rev Immunol"},{"key":"BFonc2014319_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrc3035","volume":"11","author":"P Ranganathan","year":"2011","unstructured":"Ranganathan P, Weaver KL, Capobianco AJ . Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011; 11: 338\u2013351.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014319_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrc1880","volume":"6","author":"C Grabher","year":"2006","unstructured":"Grabher C, von Boehmer H, Look AT . Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006; 6: 347\u2013359.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014319_CR23","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1084\/jem.20111855","volume":"208","author":"C Lobry","year":"2011","unstructured":"Lobry C, Oh P, Aifantis I . Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J Exp Med 2011; 208: 1931\u20131935.","journal-title":"J Exp Med"},{"key":"BFonc2014319_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm2009","volume":"7","author":"SJ Bray","year":"2006","unstructured":"Bray SJ . Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7: 678\u2013689.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014319_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrd4252","volume":"13","author":"ER Andersson","year":"2014","unstructured":"Andersson ER, Lendahl U . Therapeutic modulation of Notch signalling\u2014are we there yet? Nat Rev Drug Discov 2014; 13: 357\u2013378.","journal-title":"Nat Rev Drug Discov"},{"key":"BFonc2014319_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymeth.2012.07.008","volume":"58","author":"R Falk","year":"2012","unstructured":"Falk R, Falk A, Dyson MR, Melidoni AN, Parthiban K, Young JL et al. Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells. Methods 2012; 58: 69\u201378.","journal-title":"Methods"},{"key":"BFonc2014319_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature08543","volume":"462","author":"RE Moellering","year":"2009","unstructured":"Moellering RE, Cornejo M, Davis TN, Bianco CD, Aster JC, Blacklow SC et al. Direct inhibition of the NOTCH transcription factor complex. Nature 2009; 462: 182\u2013188.","journal-title":"Nature"},{"key":"BFonc2014319_CR28","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1158\/0008-5472.CAN-08-4295","volume":"69","author":"SS Rao","year":"2009","unstructured":"Rao SS, O'Neil J, Liberator CD, Hardwick JS, Dai X, Zhang T et al. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell Acute lymphoblastic leukemia cells. Cancer Res 2009; 69: 3060\u20133068.","journal-title":"Cancer Res"},{"key":"BFonc2014319_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-1-4614-0899-4_23","volume":"727","author":"B Purow","year":"2012","unstructured":"Purow B . Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol 2012; 727: 305\u2013319.","journal-title":"Adv Exp Med Biol"},{"key":"BFonc2014319_CR30","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/nm.2580","volume":"17","author":"DR Robinson","year":"2011","unstructured":"Robinson DR, Kalyana-Sundaram S, Wu Y-M, Shankar S, Cao X, Ateeq B et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 2011; 17: 1646\u20131651.","journal-title":"Nat Med"},{"key":"BFonc2014319_CR31","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/nrm2293","volume":"8","author":"R Geiss-Friedlander","year":"2007","unstructured":"Geiss-Friedlander R, Melchior F . Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8: 947\u2013956.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014319_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrm3011","volume":"11","author":"JR Gareau","year":"2010","unstructured":"Gareau JR, Lima CD . The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol 2010; 11: 861\u2013871.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014319_CR33","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1101\/gad.1214604","volume":"18","author":"G Gill","year":"2004","unstructured":"Gill G . SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 2004; 18: 2046\u20132059.","journal-title":"Genes Dev"},{"key":"BFonc2014319_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrm1200","volume":"4","author":"J-S Seeler","year":"2003","unstructured":"Seeler J-S, Dejean A . Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 2003; 4: 690\u2013699.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014319_CR35","doi-asserted-by":"publisher","first-page":"13225","DOI":"10.1073\/pnas.1735528100","volume":"100","author":"Y Shiio","year":"2003","unstructured":"Shiio Y, Eisenman RN . Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci 2003; 100: 13225\u201313230.","journal-title":"Proc Natl Acad Sci"},{"key":"BFonc2014319_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.molcel.2008.05.022","volume":"31","author":"P Knipscheer","year":"2008","unstructured":"Knipscheer P, Flotho A, Klug H, Olsen JV, van Dijk WJ, Fish A et al. Ubc9 sumoylation regulates SUMO target discrimination. Mol Cell 2008; 31: 371\u2013382.","journal-title":"Mol Cell"},{"key":"BFonc2014319_CR37","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1038\/sj.onc.1208210","volume":"24","author":"Y-Y Mo","year":"2005","unstructured":"Mo Y-Y, Yu Y, Theodosiou E, Rachel Ee PL, Beck WT . A role for Ubc9 in tumorigenesis. Oncogene 2005; 24: 2677\u20132683.","journal-title":"Oncogene"},{"key":"BFonc2014319_CR38","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1038\/sj.onc.1210216","volume":"26","author":"SJ Moschos","year":"2007","unstructured":"Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM et al. SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene 2007; 26: 4216\u20134225.","journal-title":"Oncogene"},{"key":"BFonc2014319_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature11005","volume":"483","author":"MJ Garnett","year":"2012","unstructured":"Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012; 483: 570\u2013575.","journal-title":"Nature"},{"key":"BFonc2014319_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603\u2013307.","journal-title":"Nature"},{"key":"BFonc2014319_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1158\/2159-8290.CD-11-0224","volume":"2","author":"R Marcotte","year":"2011","unstructured":"Marcotte R, Brown KR, Suarez F, Sayad A, Karamboulas K, Krzyzanowski PM et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov 2011; 2: 172\u2013189.","journal-title":"Cancer Discov"},{"key":"BFonc2014319_CR42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nchembio.695","volume":"7","author":"MK Muellner","year":"2011","unstructured":"Muellner MK, Uras IZ, Gapp BV, Kerzendorfer C, Smida M, Lechtermann H et al. A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nat Chem Biol 2011; 7: 787\u2013793.","journal-title":"Nat Chem Biol"},{"key":"BFonc2014319_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.chembiol.2009.01.009","volume":"16","author":"I Fukuda","year":"2009","unstructured":"Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H et al. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 2009; 16: 133\u2013140.","journal-title":"Chem Biol"},{"key":"BFonc2014319_CR44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/377355a0","volume":"377","author":"S Jarriault","year":"1995","unstructured":"Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A . Signalling downstream of activated mammalian Notch. Nature 1995; 377: 355\u2013358.","journal-title":"Nature"},{"key":"BFonc2014319_CR45","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 2005; 102: 15545\u201315550.","journal-title":"Proc Natl Acad Sci"},{"key":"BFonc2014319_CR46","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature03665","volume":"436","author":"B Pfander","year":"2005","unstructured":"Pfander B, Moldovan G-L, Sacher M, Hoege C, Jentsch S . SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature 2005; 436: 428\u2013433.","journal-title":"Nature"},{"key":"BFonc2014319_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2005.03.012","volume":"18","author":"RT Hay","year":"2005","unstructured":"Hay RT . Sumo: a history of modification. Mol Cell 2005; 18: 1\u201312.","journal-title":"Mol Cell"},{"key":"BFonc2014319_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.1212728","volume":"335","author":"JD Kessler","year":"2011","unstructured":"Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 2011; 335: 348\u2013353.","journal-title":"Science"},{"key":"BFonc2014319_CR49","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1074\/jbc.273.6.3117","volume":"273","author":"T Kamitani","year":"1998","unstructured":"Kamitani T, Nguyen HP, Kito K, Fukuda-Kamitani T, Yeh ET . Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem 1998; 273: 3117\u20133120.","journal-title":"J Biol Chem"},{"key":"BFonc2014319_CR50","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","volume":"124","author":"J Moffat","year":"2006","unstructured":"Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006; 124: 1283\u20131298.","journal-title":"Cell"},{"key":"BFonc2014319_CR51","doi-asserted-by":"publisher","first-page":"R104","DOI":"10.1186\/gb-2011-12-10-r104","volume":"12","author":"D Sims","year":"2011","unstructured":"Sims D, Mendes-Pereira AM, Frankum J, Burgess D, Cerone M-A, Lombardelli C et al. High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing. Genome Biol 2011; 12: R104.","journal-title":"Genome Biol"},{"key":"BFonc2014319_CR52","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1128\/MCB.20.12.4188-4198.2000","volume":"20","author":"ML Whitfield","year":"2000","unstructured":"Whitfield ML, Zheng LX, Baldwin A, Ohta T, Hurt MM, Marzluff WF . Stem-loop binding protein, the protein that binds the 3' end of histone mRNA, is cell cycle regulated by both translational and posttranslational mechanisms. Mol Cell Biol 2000; 20: 4188\u20134198.","journal-title":"Mol Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014319","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:11:00Z","timestamp":1647893460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,29]]},"references-count":52,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["BFonc2014319"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.319","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,29]]},"assertion":[{"value":"17 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}